4/A//SEC Filing
Sistilli Carlo 4/A
Accession 0001654954-20-000336
CIK 0001540159other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 8:30 AM ET
Size
10.1 KB
Accession
0001654954-20-000336
Insider Transaction Report
Form 4/AAmended
Sistilli Carlo
Director
Transactions
- Award
Common Share Warrants (Right to Buy)
2020-01-08+1,827→ 1,827 total(indirect: Held by York-Cav Enterprises, Inc.)Exercise: $4.80From: 2020-07-08Exp: 2023-07-08→ Common Shares (1,827 underlying) - Award
Common Shares
2020-01-08$4.11/sh+2,436$10,012→ 2,436 total(indirect: Held by York-Cav Enterprises, Inc.) - Award
Common Share Warrants (Right to Buy)
2020-01-08+1,218→ 1,218 total(indirect: Held by York-Cav Enterprises, Inc.)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (1,218 underlying)
Footnotes (5)
- [F1]The reported securities are included within 2,436 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share.
- [F2]York-Cav Enterprises, Inc. is partially owned by the reporting party.Mr. Sistilli disclaims beneficial ownership except to the extent of his precautionary interest therein.
- [F3]Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023.
- [F4]Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020.
- [F5]Amended to reflect acquisition from the issuer.
Documents
Issuer
Edesa Biotech, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001777988
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 8:30 AM ET
- Size
- 10.1 KB